Moreover, the FDA-approved anticoagulant drug warfarin, a small-molecule inhibitor of VKORC1L1, suppresses tumor growth by inducing ferroptotic cell death in vivo, indicating that warfarin may be a potential anticancer drug, especially for cancer patients with high VKORC1L1 expression. Here, VKORC1L1 is linked to neoplasm.